Company & Sponsor Intelligence

State University of New York at Buffalo

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting4

Completed3

Countries1

Therapeutic footprint

adhddementia_othermultiple_sclerosispain_neuropathyparkinsons

Indexed studies

NCT05127616EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
pain_neuropathy · United StatesNA

NCT03046251Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
multiple_sclerosis · United StatesPHASE4

NCT03747887Enhancing IEPs of Children With ADHD Using Daily Report Cards
adhd · United StatesNA

NCT05762796Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
dementia_other · United StatesNA

NCT06339034Repurposing Lithium for Parkinson's Disease: a RCT
parkinsons · United StatesPHASE1, PHASE2

NCT00918567Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
adhd · United StatesPHASE4

NCT07403539Speech Learning and Speech Production in Parkinson's Disease
parkinsons · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →